2003
DOI: 10.1016/s0306-4522(02)00954-5
|View full text |Cite
|
Sign up to set email alerts
|

Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
159
2

Year Published

2003
2003
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 217 publications
(172 citation statements)
references
References 48 publications
11
159
2
Order By: Relevance
“…In the normal brain, IBA-1 is highly expressed in resident microglial cells, but is never expressed in neurons and astrocytes [22]. After ischemia, IBA-1 is also expressed in activated resident microglial cells and infiltrating hematogenous macrophages [23,24]. …”
Section: Discussionmentioning
confidence: 99%
“…In the normal brain, IBA-1 is highly expressed in resident microglial cells, but is never expressed in neurons and astrocytes [22]. After ischemia, IBA-1 is also expressed in activated resident microglial cells and infiltrating hematogenous macrophages [23,24]. …”
Section: Discussionmentioning
confidence: 99%
“…To continue the exploration of the uses of exogenous microglia, we are currently isolating microglia from bone marrow (Ono et al, 1999;Tanaka et al, 2003). In the future, the administration of microglia might be a potential tool for cell or gene therapy in the treatment of brain disease.…”
Section: Discussionmentioning
confidence: 99%
“…Several lines of evidence suggest that tissue injury enhances the recruitment of haematopoietic stem cells, mescenchymal stem cells, or their progeny towards a non-haematopoietic fate [11,14,15,16]. This might be because migration of bone marrow stem cells throughout the body essentially act as a back-up system to augment each organ's intrinsic regenerative capacity.…”
mentioning
confidence: 99%
“…To elucidate the potential of bone marrow-derived cells for use as beta-cell replacement therapy, we established chimeric mice with the bone marrow of transgenic mice constitutively expressing enhanced green fluorescent protein (EGFP) [16,21,22,23]. As we showed previously, the bone marrow of these chimeric mice is almost completely reconstituted with EGFP-positive cells 5 weeks after transplantation [22].…”
mentioning
confidence: 99%